We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Jak2 Inhibitor X Flll32
List Price $286.52 Your Price $286.52
Sigma-Aldrich Jak2 Inhibitor X Flll32 - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-5301530001
MFG.PART: 5301530001
UNSPSC: 12352200
Manufacturer: Sigma-Aldrich


Assay
≥98% (HPLC)
Quality Level
100
Form
powder
Potency
5 μM IC50
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
yellow
Solubility
DMSO: 100 mg/mL
Storage Temp.
2-8°C
General Description
A cell permeable diketone analog of curcumin that acts as a specific inhibitor of JAK2 (~ 5 µM) and blocks STAT3 phosphorylation in MDA-MB-231 breast and PANC-1 pancreatic cancer cells. However, it does not affect STAT3 phosphorylation in normal human mammary epithelial cells or human pancreatic duct epithelial cells. Does not block the activity of tyrosine kinases containing SH2 and SH2-SH3 domains and several other kinases, such as Akt2, Cdk2-cyclin D1, EGFR kinase, Met, and EbrB2/Her2 kinase (IC50>100 µM). Also shown to block DNA binding activity of STAT3. Significantly reduces the viability and invasion capacity of various cancer cells (IC50= 640 nM; 110 nM, 140 nM, 600 nM, 400 nM in PANC-1, HPAC, MDA-MB-231, SK-BR3, and SUM-159 cells, respectively) and induces apoptosis. Shown to significantly reduce tumor burdens in the MDA-MB-231 xenografted mice.A cell permeable diketone analog of curcumin that acts as a specific inhibitor of JAK2 (~ 5 µM) and blocks STAT3 phosphorylation in MDA-MB-231 breast and PANC-1 pancreatic cancer cells. However, it does not affect STAT3 phosphorylation in normal human mammary epithelial cells or human pancreatic duct epithelial cells. Does not block the activity of tyrosine kinases containing SH2 and SH2-SH3 domains and several other kinases, such as Akt2, Cdk2-cyclin D1, EGFR kinase, Met, and EbrB2/Her2 kinase (IC50>100 µM). Also shown to block DNA binding activity of STAT3. Significantly reduces the viability and invasion capacity of various cancer cells (IC50= 640 nM; 110 nM, 140 nM, 600 nM, 400 nM in PANC-1, HPAC, MDA-MB-231, SK-BR3, and SUM-159 cells, respectively) and induces apoptosis. Shown to significantly reduce tumor burdens in the MDA-MB-231 xenografted mice.Please note that the molecular weight for this compound is batch-specific due to variable water content.
Biochem/Physiol Actions
Cell permeable: yesPrimary TargetJAK2Reversible: yes
Packaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.Other Notes
Wu, J., et Al. 2014.Oncogene 33,173.Onimoe, g., et Al. 2012.Invest. New Drugs 30,916.
Li, L., et Al. 2010.Cancer Res. 70,2445.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
| SKU | SIAL-5301530001 |
|---|---|
| Supplier Part Number | 5301530001 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 10.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

